A new experimental drug is showing remarkable promise for children with Dravet syndrome, a severe genetic form of epilepsy.

A first-in-class gene-regulating therapy cut seizures by up to 91% in children with Dravet syndrome in extension studies, ...

Findings published by The BMJ reinforce previous research linking use of the antiseizure drug valproate during pregnancy to neurodevelopmental disorders such as ADHD and autism in children, and ...

Families are an integral part of raising awareness about mortality in epilepsy and sudden unexpected death in epilepsy (SUDEP). Find out how sharing your story can drive change.

A Phase I/IIa clinical trials co-led by Linda Laux, MD, from Ann & Robert H. Lurie Children's Hospital of Chicago, show that ...

Researchers recorded brain activity directly in epilepsy patients and found that a short cycling session increased ...

An experimental drug reduced seizures by up to 91% in children with Dravet syndrome. | Drug Discovery And Development ...

You probably heard it in biology class: mitochondria are the powerhouse of the cell. You memorized it, put it on your test, and moved on.

Fort Myers, Florida - March 04, 2026 - PRESSADVANTAGE - WhiteSands Treatment Center has published a new educational ...

For families of children with Dravet syndrome who have exhausted conventional treatment options, new hope is emerging.A first‑ever gene‑regulation ...

Findings published by The BMJ today reinforce previous research linking use of the antiseizure drug valproate during pregnancy to neurodevelopmental ...